nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—HTR1D—meninx—Behcet's disease	0.0891	0.108	CbGeAlD
Loxapine—HTR7—pulmonary artery—Behcet's disease	0.0279	0.0338	CbGeAlD
Loxapine—HTR7—vein—Behcet's disease	0.0254	0.0308	CbGeAlD
Loxapine—HTR7—pons—Behcet's disease	0.0198	0.024	CbGeAlD
Loxapine—HTR2A—pulmonary artery—Behcet's disease	0.0174	0.0211	CbGeAlD
Loxapine—HTR2A—vein—Behcet's disease	0.0158	0.0192	CbGeAlD
Loxapine—HTR5A—nervous system—Behcet's disease	0.0148	0.018	CbGeAlD
Loxapine—HTR5A—central nervous system—Behcet's disease	0.0143	0.0173	CbGeAlD
Loxapine—HTR1B—artery—Behcet's disease	0.0134	0.0163	CbGeAlD
Loxapine—HTR1D—artery—Behcet's disease	0.013	0.0157	CbGeAlD
Loxapine—HTR2A—pons—Behcet's disease	0.0123	0.0149	CbGeAlD
Loxapine—HTR1E—brainstem—Behcet's disease	0.0121	0.0146	CbGeAlD
Loxapine—HTR5A—brain—Behcet's disease	0.0113	0.0137	CbGeAlD
Loxapine—HTR1B—blood vessel—Behcet's disease	0.0104	0.0127	CbGeAlD
Loxapine—HTR7—artery—Behcet's disease	0.0103	0.0125	CbGeAlD
Loxapine—HTR1D—blood vessel—Behcet's disease	0.0101	0.0123	CbGeAlD
Loxapine—HTR7—endothelium—Behcet's disease	0.00873	0.0106	CbGeAlD
Loxapine—HTR7—blood vessel—Behcet's disease	0.00805	0.00976	CbGeAlD
Loxapine—CHRM5—eye—Behcet's disease	0.00805	0.00976	CbGeAlD
Loxapine—HRH2—skin of body—Behcet's disease	0.00733	0.00889	CbGeAlD
Loxapine—DRD1—brainstem—Behcet's disease	0.00705	0.00854	CbGeAlD
Loxapine—CHRM5—skin of body—Behcet's disease	0.00701	0.00849	CbGeAlD
Loxapine—HTR3A—brainstem—Behcet's disease	0.00681	0.00825	CbGeAlD
Loxapine—HTR7—mouth—Behcet's disease	0.00674	0.00817	CbGeAlD
Loxapine—HTR2A—artery—Behcet's disease	0.00645	0.00782	CbGeAlD
Loxapine—HRH2—cardiac atrium—Behcet's disease	0.00641	0.00777	CbGeAlD
Loxapine—HTR1E—nervous system—Behcet's disease	0.00632	0.00767	CbGeAlD
Loxapine—HTR1E—central nervous system—Behcet's disease	0.00609	0.00738	CbGeAlD
Loxapine—HTR1B—brainstem—Behcet's disease	0.00571	0.00692	CbGeAlD
Loxapine—SLC6A3—brainstem—Behcet's disease	0.00566	0.00686	CbGeAlD
Loxapine—DRD4—brain—Behcet's disease	0.00561	0.0068	CbGeAlD
Loxapine—CHRM4—nervous system—Behcet's disease	0.00555	0.00672	CbGeAlD
Loxapine—HTR1D—brainstem—Behcet's disease	0.00553	0.0067	CbGeAlD
Loxapine—HTR2C—brainstem—Behcet's disease	0.00547	0.00664	CbGeAlD
Loxapine—HTR2A—endothelium—Behcet's disease	0.00545	0.0066	CbGeAlD
Loxapine—HTR1D—eye—Behcet's disease	0.00538	0.00652	CbGeAlD
Loxapine—CHRM4—central nervous system—Behcet's disease	0.00534	0.00647	CbGeAlD
Loxapine—SLC6A4—brainstem—Behcet's disease	0.00519	0.00629	CbGeAlD
Loxapine—DRD3—nervous system—Behcet's disease	0.00516	0.00625	CbGeAlD
Loxapine—HTR2A—blood vessel—Behcet's disease	0.00502	0.00609	CbGeAlD
Loxapine—DRD3—central nervous system—Behcet's disease	0.00496	0.00602	CbGeAlD
Loxapine—HTR6—nervous system—Behcet's disease	0.00496	0.00602	CbGeAlD
Loxapine—HTR1E—brain—Behcet's disease	0.00483	0.00586	CbGeAlD
Loxapine—DRD5—nervous system—Behcet's disease	0.00483	0.00586	CbGeAlD
Loxapine—HTR6—central nervous system—Behcet's disease	0.00478	0.00579	CbGeAlD
Loxapine—DRD5—central nervous system—Behcet's disease	0.00465	0.00564	CbGeAlD
Loxapine—HTR1A—brainstem—Behcet's disease	0.00461	0.00558	CbGeAlD
Loxapine—SLC6A2—brainstem—Behcet's disease	0.00457	0.00554	CbGeAlD
Loxapine—HRH2—nervous system—Behcet's disease	0.00454	0.0055	CbGeAlD
Loxapine—DRD1—midbrain—Behcet's disease	0.00449	0.00544	CbGeAlD
Loxapine—HTR7—brainstem—Behcet's disease	0.0044	0.00534	CbGeAlD
Loxapine—HRH2—central nervous system—Behcet's disease	0.00437	0.0053	CbGeAlD
Loxapine—CHRM5—nervous system—Behcet's disease	0.00433	0.00525	CbGeAlD
Loxapine—ADRA1A—brainstem—Behcet's disease	0.00425	0.00515	CbGeAlD
Loxapine—CHRM4—brain—Behcet's disease	0.00424	0.00514	CbGeAlD
Loxapine—CHRM5—central nervous system—Behcet's disease	0.00417	0.00506	CbGeAlD
Loxapine—DRD2—brainstem—Behcet's disease	0.00416	0.00505	CbGeAlD
Loxapine—DRD2—eye—Behcet's disease	0.00405	0.00491	CbGeAlD
Loxapine—DRD2—retina—Behcet's disease	0.00402	0.00487	CbGeAlD
Loxapine—ADRB1—cardiac atrium—Behcet's disease	0.00397	0.00482	CbGeAlD
Loxapine—ADRA1B—nervous system—Behcet's disease	0.00396	0.0048	CbGeAlD
Loxapine—DRD3—brain—Behcet's disease	0.00394	0.00478	CbGeAlD
Loxapine—HTR2C—medulla oblongata—Behcet's disease	0.00382	0.00463	CbGeAlD
Loxapine—ADRA1B—central nervous system—Behcet's disease	0.00381	0.00462	CbGeAlD
Loxapine—HTR6—brain—Behcet's disease	0.00379	0.0046	CbGeAlD
Loxapine—DRD5—brain—Behcet's disease	0.00369	0.00448	CbGeAlD
Loxapine—DRD1—nervous system—Behcet's disease	0.00369	0.00448	CbGeAlD
Loxapine—HTR1B—midbrain—Behcet's disease	0.00364	0.00441	CbGeAlD
Loxapine—SLC6A3—midbrain—Behcet's disease	0.00361	0.00437	CbGeAlD
Loxapine—HTR3A—nervous system—Behcet's disease	0.00357	0.00432	CbGeAlD
Loxapine—DRD1—central nervous system—Behcet's disease	0.00355	0.00431	CbGeAlD
Loxapine—HTR1B—spinal cord—Behcet's disease	0.00355	0.0043	CbGeAlD
Loxapine—HTR1D—midbrain—Behcet's disease	0.00352	0.00427	CbGeAlD
Loxapine—SLC6A3—spinal cord—Behcet's disease	0.00352	0.00427	CbGeAlD
Loxapine—HTR2C—midbrain—Behcet's disease	0.00349	0.00423	CbGeAlD
Loxapine—HRH2—brain—Behcet's disease	0.00347	0.0042	CbGeAlD
Loxapine—HTR3A—central nervous system—Behcet's disease	0.00343	0.00416	CbGeAlD
Loxapine—HTR2C—spinal cord—Behcet's disease	0.0034	0.00413	CbGeAlD
Loxapine—CHRM5—brain—Behcet's disease	0.00331	0.00402	CbGeAlD
Loxapine—SLC6A4—midbrain—Behcet's disease	0.00331	0.00401	CbGeAlD
Loxapine—SLC6A4—spinal cord—Behcet's disease	0.00323	0.00391	CbGeAlD
Loxapine—HRH1—eye—Behcet's disease	0.0032	0.00388	CbGeAlD
Loxapine—SLC6A2—medulla oblongata—Behcet's disease	0.00319	0.00386	CbGeAlD
Loxapine—ADRA2C—mammalian vulva—Behcet's disease	0.00313	0.00379	CbGeAlD
Loxapine—HTR7—medulla oblongata—Behcet's disease	0.00307	0.00372	CbGeAlD
Loxapine—ADRA1B—brain—Behcet's disease	0.00303	0.00367	CbGeAlD
Loxapine—ADRA2C—cardiac atrium—Behcet's disease	0.00299	0.00363	CbGeAlD
Loxapine—HTR1B—nervous system—Behcet's disease	0.00299	0.00363	CbGeAlD
Loxapine—CHRM2—nervous system—Behcet's disease	0.00298	0.00361	CbGeAlD
Loxapine—SLC6A3—nervous system—Behcet's disease	0.00297	0.0036	CbGeAlD
Loxapine—HTR1A—midbrain—Behcet's disease	0.00294	0.00356	CbGeAlD
Loxapine—HTR1D—nervous system—Behcet's disease	0.0029	0.00351	CbGeAlD
Loxapine—HTR1B—central nervous system—Behcet's disease	0.00288	0.00349	CbGeAlD
Loxapine—HTR2C—nervous system—Behcet's disease	0.00287	0.00348	CbGeAlD
Loxapine—HTR1A—spinal cord—Behcet's disease	0.00286	0.00347	CbGeAlD
Loxapine—CHRM2—central nervous system—Behcet's disease	0.00286	0.00347	CbGeAlD
Loxapine—SLC6A3—central nervous system—Behcet's disease	0.00286	0.00346	CbGeAlD
Loxapine—ADRA2C—medulla oblongata—Behcet's disease	0.00282	0.00342	CbGeAlD
Loxapine—DRD1—brain—Behcet's disease	0.00282	0.00342	CbGeAlD
Loxapine—ADRB1—nervous system—Behcet's disease	0.00281	0.00341	CbGeAlD
Loxapine—HTR7—midbrain—Behcet's disease	0.00281	0.0034	CbGeAlD
Loxapine—HTR1D—central nervous system—Behcet's disease	0.00279	0.00338	CbGeAlD
Loxapine—HTR2C—central nervous system—Behcet's disease	0.00276	0.00335	CbGeAlD
Loxapine—HTR2A—brainstem—Behcet's disease	0.00275	0.00333	CbGeAlD
Loxapine—HTR7—spinal cord—Behcet's disease	0.00274	0.00332	CbGeAlD
Loxapine—HTR3A—brain—Behcet's disease	0.00273	0.0033	CbGeAlD
Loxapine—SLC6A4—nervous system—Behcet's disease	0.00272	0.0033	CbGeAlD
Loxapine—ADRB1—central nervous system—Behcet's disease	0.00271	0.00328	CbGeAlD
Loxapine—CHRM1—nervous system—Behcet's disease	0.00271	0.00328	CbGeAlD
Loxapine—HTR2A—eye—Behcet's disease	0.00267	0.00324	CbGeAlD
Loxapine—DRD2—midbrain—Behcet's disease	0.00265	0.00322	CbGeAlD
Loxapine—HTR2A—retina—Behcet's disease	0.00265	0.00321	CbGeAlD
Loxapine—SLC6A4—central nervous system—Behcet's disease	0.00262	0.00317	CbGeAlD
Loxapine—CHRM1—central nervous system—Behcet's disease	0.00261	0.00316	CbGeAlD
Loxapine—ADRA2C—midbrain—Behcet's disease	0.00258	0.00313	CbGeAlD
Loxapine—HRH1—mammalian vulva—Behcet's disease	0.00254	0.00308	CbGeAlD
Loxapine—ADRA2C—spinal cord—Behcet's disease	0.00252	0.00305	CbGeAlD
Loxapine—ADRA2A—mammalian vulva—Behcet's disease	0.00249	0.00302	CbGeAlD
Loxapine—CHRM3—nervous system—Behcet's disease	0.00242	0.00294	CbGeAlD
Loxapine—HTR1A—nervous system—Behcet's disease	0.00241	0.00293	CbGeAlD
Loxapine—SLC6A2—nervous system—Behcet's disease	0.00239	0.0029	CbGeAlD
Loxapine—ADRA2A—cardiac atrium—Behcet's disease	0.00239	0.0029	CbGeAlD
Loxapine—CHRM3—central nervous system—Behcet's disease	0.00233	0.00283	CbGeAlD
Loxapine—HTR1A—central nervous system—Behcet's disease	0.00232	0.00282	CbGeAlD
Loxapine—HTR7—nervous system—Behcet's disease	0.00231	0.0028	CbGeAlD
Loxapine—SLC6A2—central nervous system—Behcet's disease	0.0023	0.00279	CbGeAlD
Loxapine—HTR1B—brain—Behcet's disease	0.00229	0.00277	CbGeAlD
Loxapine—CHRM2—brain—Behcet's disease	0.00227	0.00276	CbGeAlD
Loxapine—SLC6A3—brain—Behcet's disease	0.00227	0.00275	CbGeAlD
Loxapine—ADRA2A—medulla oblongata—Behcet's disease	0.00225	0.00273	CbGeAlD
Loxapine—ADRA1A—nervous system—Behcet's disease	0.00223	0.0027	CbGeAlD
Loxapine—HTR7—central nervous system—Behcet's disease	0.00222	0.00269	CbGeAlD
Loxapine—HTR1D—brain—Behcet's disease	0.00221	0.00268	CbGeAlD
Loxapine—HTR2C—brain—Behcet's disease	0.00219	0.00266	CbGeAlD
Loxapine—DRD2—nervous system—Behcet's disease	0.00218	0.00264	CbGeAlD
Loxapine—ADRB1—brain—Behcet's disease	0.00215	0.00261	CbGeAlD
Loxapine—ADRA1A—central nervous system—Behcet's disease	0.00214	0.0026	CbGeAlD
Loxapine—ADRA2C—nervous system—Behcet's disease	0.00212	0.00257	CbGeAlD
Loxapine—DRD2—central nervous system—Behcet's disease	0.0021	0.00255	CbGeAlD
Loxapine—SLC6A4—brain—Behcet's disease	0.00208	0.00252	CbGeAlD
Loxapine—CHRM1—brain—Behcet's disease	0.00207	0.00251	CbGeAlD
Loxapine—ADRA2A—midbrain—Behcet's disease	0.00206	0.00249	CbGeAlD
Loxapine—ADRA2C—central nervous system—Behcet's disease	0.00204	0.00247	CbGeAlD
Loxapine—ADRA2A—spinal cord—Behcet's disease	0.00201	0.00243	CbGeAlD
Loxapine—HTR2A—medulla oblongata—Behcet's disease	0.00191	0.00232	CbGeAlD
Loxapine—CHRM3—brain—Behcet's disease	0.00185	0.00225	CbGeAlD
Loxapine—HTR1A—brain—Behcet's disease	0.00185	0.00224	CbGeAlD
Loxapine—SLC6A2—brain—Behcet's disease	0.00183	0.00222	CbGeAlD
Loxapine—HTR7—brain—Behcet's disease	0.00176	0.00214	CbGeAlD
Loxapine—HTR2A—midbrain—Behcet's disease	0.00175	0.00212	CbGeAlD
Loxapine—HRH1—nervous system—Behcet's disease	0.00172	0.00209	CbGeAlD
Loxapine—HTR2A—spinal cord—Behcet's disease	0.00171	0.00207	CbGeAlD
Loxapine—ADRA1A—brain—Behcet's disease	0.0017	0.00206	CbGeAlD
Loxapine—ADRA2A—nervous system—Behcet's disease	0.00169	0.00205	CbGeAlD
Loxapine—DRD2—brain—Behcet's disease	0.00167	0.00202	CbGeAlD
Loxapine—HRH1—central nervous system—Behcet's disease	0.00166	0.00201	CbGeAlD
Loxapine—ADRA2A—central nervous system—Behcet's disease	0.00163	0.00197	CbGeAlD
Loxapine—ADRA2C—brain—Behcet's disease	0.00162	0.00196	CbGeAlD
Loxapine—HTR2A—nervous system—Behcet's disease	0.00144	0.00174	CbGeAlD
Loxapine—HTR2A—central nervous system—Behcet's disease	0.00139	0.00168	CbGeAlD
Loxapine—HRH1—brain—Behcet's disease	0.00132	0.0016	CbGeAlD
Loxapine—ADRA2A—brain—Behcet's disease	0.00129	0.00157	CbGeAlD
Loxapine—HTR2A—brain—Behcet's disease	0.0011	0.00133	CbGeAlD
Loxapine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000176	0.00101	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CCR1—Behcet's disease	0.000175	0.001	CbGpPWpGaD
Loxapine—SLC6A3—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000175	0.000998	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—NOS3—Behcet's disease	0.000174	0.000993	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CCR1—Behcet's disease	0.000174	0.000992	CbGpPWpGaD
Loxapine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000174	0.000992	CbGpPWpGaD
Loxapine—CHRM5—GPCR ligand binding—CXCL8—Behcet's disease	0.000169	0.000968	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CCR1—Behcet's disease	0.000168	0.000958	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CCR1—Behcet's disease	0.000167	0.000953	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CCR1—Behcet's disease	0.000162	0.000927	CbGpPWpGaD
Loxapine—HRH4—Signaling by GPCR—CXCL8—Behcet's disease	0.000162	0.000924	CbGpPWpGaD
Loxapine—DRD1—GPCR ligand binding—CXCL8—Behcet's disease	0.000161	0.000922	CbGpPWpGaD
Loxapine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.00016	0.000914	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CCR1—Behcet's disease	0.00016	0.000912	CbGpPWpGaD
Loxapine—DRD3—GPCR ligand binding—CXCL8—Behcet's disease	0.000159	0.00091	CbGpPWpGaD
Loxapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000157	0.0009	CbGpPWpGaD
Loxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000157	0.000898	CbGpPWpGaD
Loxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000157	0.000895	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—APOB—Behcet's disease	0.000156	0.000894	CbGpPWpGaD
Loxapine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000156	0.000892	CbGpPWpGaD
Loxapine—HTR1E—GPCR downstream signaling—CXCL8—Behcet's disease	0.000155	0.000886	CbGpPWpGaD
Loxapine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000155	0.000883	CbGpPWpGaD
Loxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000154	0.000881	CbGpPWpGaD
Loxapine—HTR5A—Signaling Pathways—CXCL8—Behcet's disease	0.000154	0.00088	CbGpPWpGaD
Loxapine—ADRA2B—Hemostasis—SERPINE1—Behcet's disease	0.000152	0.000867	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CCR1—Behcet's disease	0.000147	0.000841	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—APOA1—Behcet's disease	0.000145	0.000829	CbGpPWpGaD
Loxapine—ADRB1—GPCR ligand binding—CXCL8—Behcet's disease	0.000145	0.000829	CbGpPWpGaD
Loxapine—ADRA2B—Hemostasis—NOS3—Behcet's disease	0.000145	0.000828	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CCR1—Behcet's disease	0.000145	0.000827	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CCR1—Behcet's disease	0.000144	0.000825	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CCR1—Behcet's disease	0.000144	0.000823	CbGpPWpGaD
Loxapine—ADRA2B—GPCR ligand binding—CXCL8—Behcet's disease	0.000144	0.000821	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CCR1—Behcet's disease	0.000144	0.00082	CbGpPWpGaD
Loxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000143	0.000818	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—APOA1—Behcet's disease	0.000142	0.000812	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CCR1—Behcet's disease	0.000142	0.000812	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—SERPINE1—Behcet's disease	0.000142	0.00081	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CCR1—Behcet's disease	0.000142	0.00081	CbGpPWpGaD
Loxapine—HTR1E—Signaling by GPCR—CXCL8—Behcet's disease	0.000141	0.000805	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—APOB—Behcet's disease	0.000139	0.000796	CbGpPWpGaD
Loxapine—HTR1A—GPCR ligand binding—CXCL8—Behcet's disease	0.000139	0.000793	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—APOB—Behcet's disease	0.000138	0.000791	CbGpPWpGaD
Loxapine—HRH2—GPCR downstream signaling—CXCL8—Behcet's disease	0.000138	0.000789	CbGpPWpGaD
Loxapine—HTR2C—GPCR ligand binding—CXCL8—Behcet's disease	0.000138	0.000789	CbGpPWpGaD
Loxapine—DRD5—GPCR downstream signaling—CXCL8—Behcet's disease	0.000137	0.000784	CbGpPWpGaD
Loxapine—ADRA2C—Hemostasis—NOS3—Behcet's disease	0.000135	0.000774	CbGpPWpGaD
Loxapine—ADRA2C—GPCR ligand binding—CXCL8—Behcet's disease	0.000134	0.000767	CbGpPWpGaD
Loxapine—ADRA1B—GPCR ligand binding—CXCL8—Behcet's disease	0.000132	0.000755	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CCR1—Behcet's disease	0.000132	0.000753	CbGpPWpGaD
Loxapine—HRH2—Signaling by GPCR—CXCL8—Behcet's disease	0.000125	0.000717	CbGpPWpGaD
Loxapine—DRD5—Signaling by GPCR—CXCL8—Behcet's disease	0.000125	0.000712	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—APOA1—Behcet's disease	0.000124	0.000707	CbGpPWpGaD
Loxapine—DRD2—GPCR ligand binding—CXCL8—Behcet's disease	0.000122	0.000696	CbGpPWpGaD
Loxapine—HTR2A—GPCR ligand binding—CXCL8—Behcet's disease	0.00012	0.000685	CbGpPWpGaD
Loxapine—HRH1—GPCR ligand binding—CXCL8—Behcet's disease	0.00012	0.000684	CbGpPWpGaD
Loxapine—CHRM1—GPCR ligand binding—CXCL8—Behcet's disease	0.000119	0.000681	CbGpPWpGaD
Loxapine—CHRM3—GPCR ligand binding—CXCL8—Behcet's disease	0.000119	0.000679	CbGpPWpGaD
Loxapine—CHRM2—GPCR ligand binding—CXCL8—Behcet's disease	0.000118	0.000673	CbGpPWpGaD
Loxapine—ADRA1A—GPCR ligand binding—CXCL8—Behcet's disease	0.000117	0.000671	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—SERPINE1—Behcet's disease	0.000115	0.000658	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—SERPINE1—Behcet's disease	0.000113	0.000645	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—APOA1—Behcet's disease	0.00011	0.00063	CbGpPWpGaD
Loxapine—ADRA2A—Hemostasis—NOS3—Behcet's disease	0.00011	0.000628	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—APOA1—Behcet's disease	0.00011	0.000626	CbGpPWpGaD
Loxapine—ADRA2A—GPCR ligand binding—CXCL8—Behcet's disease	0.000109	0.000623	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—NOS3—Behcet's disease	0.000108	0.000616	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—APOB—Behcet's disease	0.000107	0.000611	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—APOB—Behcet's disease	0.000107	0.00061	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—APOB—Behcet's disease	0.000106	0.000606	CbGpPWpGaD
Loxapine—HTR6—GPCR downstream signaling—CXCL8—Behcet's disease	0.000106	0.000605	CbGpPWpGaD
Loxapine—HTR7—GPCR downstream signaling—CXCL8—Behcet's disease	0.000106	0.000605	CbGpPWpGaD
Loxapine—HTR1D—GPCR downstream signaling—CXCL8—Behcet's disease	0.000105	0.000601	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—APOB—Behcet's disease	0.000104	0.000593	CbGpPWpGaD
Loxapine—HTR1B—GPCR downstream signaling—CXCL8—Behcet's disease	0.000103	0.000588	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—APOB—Behcet's disease	0.000102	0.000584	CbGpPWpGaD
Loxapine—DRD4—GPCR downstream signaling—CXCL8—Behcet's disease	0.000101	0.000579	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—APOB—Behcet's disease	0.000101	0.000576	CbGpPWpGaD
Loxapine—CHRM4—GPCR downstream signaling—CXCL8—Behcet's disease	0.0001	0.000571	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—SERPINE1—Behcet's disease	9.83e-05	0.000561	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—APOB—Behcet's disease	9.65e-05	0.000552	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—CXCL8—Behcet's disease	9.62e-05	0.00055	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—CXCL8—Behcet's disease	9.61e-05	0.000549	CbGpPWpGaD
Loxapine—CHRM5—GPCR downstream signaling—CXCL8—Behcet's disease	9.57e-05	0.000547	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—CXCL8—Behcet's disease	9.56e-05	0.000546	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—CXCL8—Behcet's disease	9.55e-05	0.000546	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—CAT—Behcet's disease	9.43e-05	0.000539	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—NOS3—Behcet's disease	9.38e-05	0.000536	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—CXCL8—Behcet's disease	9.35e-05	0.000534	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—CXCL8—Behcet's disease	9.2e-05	0.000526	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—APOB—Behcet's disease	9.2e-05	0.000526	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—APOB—Behcet's disease	9.15e-05	0.000523	CbGpPWpGaD
Loxapine—DRD1—GPCR downstream signaling—CXCL8—Behcet's disease	9.12e-05	0.000521	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—APOB—Behcet's disease	9.08e-05	0.000519	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—CXCL8—Behcet's disease	9.08e-05	0.000519	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—CXCL8—Behcet's disease	9e-05	0.000514	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—SERPINE1—Behcet's disease	8.75e-05	0.0005	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—SERPINE1—Behcet's disease	8.7e-05	0.000497	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—CXCL8—Behcet's disease	8.69e-05	0.000497	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—APOA1—Behcet's disease	8.46e-05	0.000483	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—APOA1—Behcet's disease	8.45e-05	0.000483	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—APOA1—Behcet's disease	8.39e-05	0.000479	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—NOS3—Behcet's disease	8.36e-05	0.000477	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—CAT—Behcet's disease	8.35e-05	0.000477	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—CXCL8—Behcet's disease	8.32e-05	0.000475	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—NOS3—Behcet's disease	8.3e-05	0.000474	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—CXCL8—Behcet's disease	8.28e-05	0.000473	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—APOB—Behcet's disease	8.27e-05	0.000473	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—APOA1—Behcet's disease	8.22e-05	0.000469	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—CXCL8—Behcet's disease	8.2e-05	0.000469	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—APOB—Behcet's disease	8.2e-05	0.000468	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—CXCL8—Behcet's disease	8.17e-05	0.000467	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—CXCL8—Behcet's disease	8.13e-05	0.000464	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—APOB—Behcet's disease	8.1e-05	0.000463	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—APOA1—Behcet's disease	8.09e-05	0.000462	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—APOA1—Behcet's disease	7.98e-05	0.000456	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—APOB—Behcet's disease	7.91e-05	0.000452	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—APOB—Behcet's disease	7.87e-05	0.00045	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—CXCL8—Behcet's disease	7.84e-05	0.000448	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—CXCL8—Behcet's disease	7.8e-05	0.000446	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—CAT—Behcet's disease	7.66e-05	0.000438	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—APOB—Behcet's disease	7.65e-05	0.000437	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—APOA1—Behcet's disease	7.64e-05	0.000436	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—CXCL8—Behcet's disease	7.59e-05	0.000434	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—APOB—Behcet's disease	7.53e-05	0.00043	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—CXCL8—Behcet's disease	7.47e-05	0.000427	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—CXCL8—Behcet's disease	7.45e-05	0.000425	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—APOB—Behcet's disease	7.44e-05	0.000425	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—CXCL8—Behcet's disease	7.41e-05	0.000423	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—CXCL8—Behcet's disease	7.38e-05	0.000422	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—CXCL8—Behcet's disease	7.36e-05	0.000421	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—APOA1—Behcet's disease	7.28e-05	0.000416	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—APOA1—Behcet's disease	7.24e-05	0.000414	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—APOA1—Behcet's disease	7.18e-05	0.00041	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—CXCL8—Behcet's disease	7.12e-05	0.000407	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—CXCL8—Behcet's disease	7.09e-05	0.000405	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—APOB—Behcet's disease	6.95e-05	0.000397	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—CXCL8—Behcet's disease	6.89e-05	0.000394	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—CXCL8—Behcet's disease	6.89e-05	0.000393	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—APOB—Behcet's disease	6.83e-05	0.00039	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—APOB—Behcet's disease	6.82e-05	0.00039	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—APOB—Behcet's disease	6.8e-05	0.000388	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—CXCL8—Behcet's disease	6.78e-05	0.000388	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—CXCL8—Behcet's disease	6.78e-05	0.000387	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—APOB—Behcet's disease	6.78e-05	0.000387	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—CXCL8—Behcet's disease	6.76e-05	0.000386	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—CXCL8—Behcet's disease	6.74e-05	0.000385	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—CXCL8—Behcet's disease	6.72e-05	0.000384	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—SERPINE1—Behcet's disease	6.71e-05	0.000383	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—APOB—Behcet's disease	6.71e-05	0.000383	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—SERPINE1—Behcet's disease	6.7e-05	0.000383	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—APOB—Behcet's disease	6.69e-05	0.000382	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—SERPINE1—Behcet's disease	6.66e-05	0.000381	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—CXCL8—Behcet's disease	6.65e-05	0.00038	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—CXCL8—Behcet's disease	6.63e-05	0.000379	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—APOA1—Behcet's disease	6.54e-05	0.000374	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—SERPINE1—Behcet's disease	6.52e-05	0.000373	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—APOA1—Behcet's disease	6.48e-05	0.00037	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—SERPINE1—Behcet's disease	6.42e-05	0.000367	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—APOA1—Behcet's disease	6.41e-05	0.000366	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—NOS3—Behcet's disease	6.41e-05	0.000366	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—NOS3—Behcet's disease	6.4e-05	0.000366	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—NOS3—Behcet's disease	6.36e-05	0.000363	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—SERPINE1—Behcet's disease	6.33e-05	0.000362	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—APOA1—Behcet's disease	6.26e-05	0.000358	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—CXCL8—Behcet's disease	6.25e-05	0.000357	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—NOS3—Behcet's disease	6.23e-05	0.000356	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—APOA1—Behcet's disease	6.23e-05	0.000356	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—APOB—Behcet's disease	6.22e-05	0.000355	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—CXCL8—Behcet's disease	6.16e-05	0.000352	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—CXCL8—Behcet's disease	6.15e-05	0.000352	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—CXCL8—Behcet's disease	6.14e-05	0.000351	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—NOS3—Behcet's disease	6.13e-05	0.00035	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—CXCL8—Behcet's disease	6.12e-05	0.00035	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—CXCL8—Behcet's disease	6.1e-05	0.000349	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—SERPINE1—Behcet's disease	6.06e-05	0.000346	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—APOA1—Behcet's disease	6.06e-05	0.000346	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—NOS3—Behcet's disease	6.05e-05	0.000345	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—CXCL8—Behcet's disease	6.04e-05	0.000345	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—CXCL8—Behcet's disease	6.03e-05	0.000344	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—APOA1—Behcet's disease	5.96e-05	0.000341	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—APOA1—Behcet's disease	5.88e-05	0.000336	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—NOS3—Behcet's disease	5.79e-05	0.000331	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—SERPINE1—Behcet's disease	5.78e-05	0.00033	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—SERPINE1—Behcet's disease	5.7e-05	0.000326	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—CXCL8—Behcet's disease	5.68e-05	0.000325	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—CXCL8—Behcet's disease	5.68e-05	0.000324	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—CXCL8—Behcet's disease	5.64e-05	0.000322	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—CXCL8—Behcet's disease	5.6e-05	0.00032	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—CXCL8—Behcet's disease	5.52e-05	0.000316	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—NOS3—Behcet's disease	5.52e-05	0.000315	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—APOA1—Behcet's disease	5.5e-05	0.000314	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—NOS3—Behcet's disease	5.49e-05	0.000314	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—NOS3—Behcet's disease	5.44e-05	0.000311	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—CXCL8—Behcet's disease	5.44e-05	0.000311	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—APOA1—Behcet's disease	5.41e-05	0.000309	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—APOA1—Behcet's disease	5.4e-05	0.000308	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—APOA1—Behcet's disease	5.38e-05	0.000307	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—CXCL8—Behcet's disease	5.36e-05	0.000306	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—APOA1—Behcet's disease	5.36e-05	0.000306	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—APOA1—Behcet's disease	5.31e-05	0.000303	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—APOA1—Behcet's disease	5.29e-05	0.000303	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—SERPINE1—Behcet's disease	5.19e-05	0.000297	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—SERPINE1—Behcet's disease	5.15e-05	0.000294	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CXCL8—Behcet's disease	5.13e-05	0.000293	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—SERPINE1—Behcet's disease	4.97e-05	0.000284	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—NOS3—Behcet's disease	4.96e-05	0.000283	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—SERPINE1—Behcet's disease	4.94e-05	0.000282	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—APOA1—Behcet's disease	4.92e-05	0.000281	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—NOS3—Behcet's disease	4.91e-05	0.000281	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CXCL8—Behcet's disease	4.89e-05	0.00028	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—NOS3—Behcet's disease	4.86e-05	0.000278	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CXCL8—Behcet's disease	4.83e-05	0.000276	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—SERPINE1—Behcet's disease	4.81e-05	0.000275	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NOS3—Behcet's disease	4.74e-05	0.000271	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—SERPINE1—Behcet's disease	4.73e-05	0.00027	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NOS3—Behcet's disease	4.72e-05	0.00027	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NOS3—Behcet's disease	4.59e-05	0.000262	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NOS3—Behcet's disease	4.52e-05	0.000258	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—NOS3—Behcet's disease	4.46e-05	0.000255	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CXCL8—Behcet's disease	4.4e-05	0.000251	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—SERPINE1—Behcet's disease	4.36e-05	0.000249	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CXCL8—Behcet's disease	4.36e-05	0.000249	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—SERPINE1—Behcet's disease	4.29e-05	0.000245	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—SERPINE1—Behcet's disease	4.28e-05	0.000245	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—SERPINE1—Behcet's disease	4.27e-05	0.000244	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—SERPINE1—Behcet's disease	4.26e-05	0.000243	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—SERPINE1—Behcet's disease	4.21e-05	0.000241	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CXCL8—Behcet's disease	4.21e-05	0.00024	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—SERPINE1—Behcet's disease	4.2e-05	0.00024	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CXCL8—Behcet's disease	4.19e-05	0.000239	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NOS3—Behcet's disease	4.16e-05	0.000238	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOS3—Behcet's disease	4.1e-05	0.000234	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOS3—Behcet's disease	4.09e-05	0.000234	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOS3—Behcet's disease	4.08e-05	0.000233	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CXCL8—Behcet's disease	4.07e-05	0.000233	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOS3—Behcet's disease	4.06e-05	0.000232	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOS3—Behcet's disease	4.02e-05	0.00023	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOS3—Behcet's disease	4.01e-05	0.000229	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CXCL8—Behcet's disease	4.01e-05	0.000229	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—SERPINE1—Behcet's disease	3.91e-05	0.000223	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOS3—Behcet's disease	3.73e-05	0.000213	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CXCL8—Behcet's disease	3.69e-05	0.000211	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CXCL8—Behcet's disease	3.64e-05	0.000208	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CXCL8—Behcet's disease	3.63e-05	0.000207	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CXCL8—Behcet's disease	3.62e-05	0.000207	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CXCL8—Behcet's disease	3.6e-05	0.000206	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CXCL8—Behcet's disease	3.57e-05	0.000204	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CXCL8—Behcet's disease	3.56e-05	0.000203	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CXCL8—Behcet's disease	3.31e-05	0.000189	CbGpPWpGaD
